Presentation

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

May 23, 2017

REGISTER for free or LOG IN to view this content

Prevalence, Management, and Long-term (6-Year) Outcomes of A-fib Among Patients Receiving DES

Clinical Pharma

Coronary

CAD Pharma

DES/BRS/DCB

Atrial Fibrillation

Heart Rhythm Pharma

Factoid

Up Next

Presentation

PFO Closure in the Gore REDUCE Clinical Trial

May 24, 2017

More slides +

Presentation

CLOSE: Closure of PFO, Oral Anticoagulants, or Antiplatelet Therapy to Prevent Stroke Recurrence

May 24, 2017

Presentation

Myocardial Damage in Patients With Deferred Stenting After STEMI

June 05, 2017

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.